Board of Directors

Members of the Board of Directors are appointed by the Minister for Health and are responsible for setting the strategic direction of the service, appointing the Chief Executive Officer and overseeing the management of the service.

Powers and duties of the Board

Monash Health is a public health service pursuant to the Health Services Act 1988 (Vic) and:

  • is a body corporate with perpetual succession
  • may sue and be sued in its corporate name
  • is capable of purchasing, taking, holding, selling, leasing, taking on lease, exchanging and disposing of real and personal property
  • is capable of doing and suffering all acts and things which bodies corporate may by law do or suffer, and
  • the board has such powers as are necessary to enable it to carry out its function, including the power to make, amend or revoke by-laws.

The function of the Board is to:

  • monitor the performance of Monash Health
  • appoint and determine the terms and conditions (including remuneration) of the Chief Executive Officer
  • monitor the management of Monash Health and performance of the Chief Executive Officer of Monash Health
  • develop statements of priorities and strategic plans for the operation of Monash Health and to monitor compliance
  • develop financial and business plans, strategies and budgets to ensure the accountable and efficient provision of health services by Monash Health and the long term financial viability
  • ensure that Monash Health operates within its budget and that its systems accurately reflect its financial position and viability
  • ensure effective and accountable systems are in place to monitor and improve the quality and effectiveness of health services provided by Monash Health
  • ensure any problems identified with the quality or effectiveness of the health services provided are addressed in a timely manner and that Monash Health continuously strives to improve the quality of the health services it provides and to foster innovation
  • develop arrangements with other agencies and health service providers to enable effective and efficient service delivery and continuity of care
  • establish the organisational structure, including the management structure, of Monash Health
  • ensure that the Minister and the Secretary are advised about significant board decisions and are informed in a timely manner of any issues of public concern or risks that affect or may affect Monash Health
  • establish a Finance Committee, an Audit Committee and a Quality and Safety Committee

Board of Directors

Dipak-Sanghvi-028-2021 Board&Exec

Mr Dipak Sanghvi

BSc Pharm (UK), FAICD, FAIPM

Chair of the Monash Health Board
Chair, Remuneration Committee
Chair, Aboriginal Health Strategic Partnership Committee
Member, Community Advisory Committee

Term of appointment: December 2015 – current

Mr Sanghvi is a pharmacist who owns a pharmacy in Victoria. He is currently Chair of Member Benefits Australia Pty Ltd and Chair of Musculoskeletal Australia. Previous positions held include President of the Pharmacy Guild Victoria Branch during 2006- 2011, Chair of Gold Cross Products and Services Pty Ltd, Chair of Return of Unwanted Medicines, being a Board member of Guild Insurance and Superannuation and Meridian Lawyers, as well as several other board positions in the community and pharmaceutical industry.

Ms Aurelia BalpeMBA, GAICD, GradDip Demog, BEcMember, Finance CommitteeMember, Primary Care and Population Health Advisory CommitteeTerm of appointment: July 2018 – current Headshots, Monash Health Board Members.Copyright Monash Health. Not for use without prior written permission.

Ms Aurélia Balpe

MBA, GAICD, GradDip Demog, BEc, GradDip Psych

Chair, Primary Care and Population Health Advisory Committee
Member, Finance Committee

Term of appointment: July 2018 – current

Ms Balpe is an international humanitarian leader with experience in the non-profit and for-profit sectors in Asia, the Pacific, the Americas, Africa and Europe.

Ms Balpe has worked with boards and senior executive teams on the development of strategy and policy, legal compliance, risk management, organisational performance and the resolution of integrity issues. Ms Balpe has had oversight of multinational programs in organisational development, disaster response and law, water and sanitation and health.

Ms Balpe has been a strategic advisor to governments, United Nations agencies, regional organisations and corporations on humanitarian action and coordination. Ms Balpe currently serves as a member of the Australian Red Cross Divisional Advisory Board. In 2015 she was awarded the Vanuatu Red Cross medal for her contribution to the Tropical Cyclone Pam Relief Operation. In 2017 she was the recipient of the Monash University Top Achievement and Dean’s Awards for her MBA.

Jane-Bell-028-2021 Board&Exec

Mrs Jane Bell

BEc, LLB, LLM (Lond), FAICD

Chair, Audit Committee
Director, Kitaya Holdings Pty Ltd*
Member, Audit Committee, Kitaya Holdings Pty Ltd*

Term of appointment: July 2018 – current

Mrs Bell is a banking and finance lawyer and non-executive director with more than 30 years’ experience in leading law firms, financial services, and corporate treasury operations gained living in Melbourne, London, Toronto, San Francisco and Brisbane. Mrs Bell has been a non-executive director since 2002, serving on 13 boards including nine health and medical research boards. Mrs Bell currently serves as a Director of Amplia Therapeutics Limited (ASX:ATX), Chair of the Community Advisory Group of the Melbourne Genomics Health Alliance and is a Member of the Administrative Appeals Tribunal. Mrs Bell is a former Chair of Melbourne Health (Royal Melbourne Hospital), Chair of Biomedical Research Vic, Deputy Chair of Westernport Water Corporation, Director of UCA Funds Management, WorkSafe Victoria, Hudson Institute of Medical Research-Monash Institute of Medical Research-Prince Henry’s Institute of Medical Research, Queensland Institute of Medical Research Trust, Australian Red Cross (Qld) and the Victorian Women’s Housing Association.

*Kitaya Holdings Pty Ltd operates Jessie McPherson Private Hospital

Headshots, Monash Health Board Members.Mr Tony BrainBCom, CA, FAIST, GAICDMember, Audit CommitteeMember, Finance CommitteeTerm of appointment: July 2019 – currentMr Brain is a Chartered Accountant with over 30 yearsâ€Â™ experience in governance, assurance, finance and regulatory oversight. Tonyâ€Â™s executive leadership experience includes 12 years as Partner at Deloitte and nearly 3 years as Head of Risk Management at AustralianSuper. In addition to Monash Health, Tonyâ€Â™s current Non-Executive Director experience includes 3 years at the Australian Scholarships Group Friendly Society Pty Ltd and nearly 1 year at AMP Superannuation Limited where he is currently in the role as Interim Chair. Tony also sits on various Board Committees for Victoria University, Barwon Health, Magistrates Court Victoria and the Alannah and Madeline Foundation. Tony is also a current member of the Companies Auditor Disciplinary Board.Copyright Monash Health. Not for use without prior written permission.

Mr Tony Brain

BCom, CA, FAIST, GAICD

Chair, Finance Committee
Member, Audit Committee
Member, Remuneration Committee

Term of appointment: July 2019 – current

Mr Brain is a Chartered Accountant with over 30 years’ experience in governance, assurance, finance and regulatory oversight.

His executive leadership experience includes 12 years as Partner at Deloitte and nearly three years as Head of Risk Management at AustralianSuper.

In addition to Monash Health, his current Board related roles include Council Member at Victoria University, Non-Executive Director at Futurity Investment Management Friendly Society and Chair of the AMP Superannuation Trustee boards. He is a member of various Board Committees for these organisations, including Chair of the Risk Committee at Futurity. He is also a member of various Risk, Finance and Audit Committees at the Alannah and Madeline Foundation, the Magistrates Court Victoria and Barwon Health.

He is a current member of the Companies Auditor Disciplinary Board.

Board Headshots.Ms Helen BruntBA (Hons), GAICDMember, Finance CommitteeTerm of appointment: July 2019 – currentMs Brunt is a senior governance and technology delivery executive who brings extensive experience in digital technology and large scale transformation in complex business environments including Wesfarmers and Westpac. She is skilled in developing strategies to leverage technology to support business strategy. Helen is passionate about diversity and the use of technology to transform customer and staff experience and previously served as an associate board member for the VIC ICT for Women in IT. Helen is currently an elected Member Director of the Wesfarmers Super Trust Policy Committee.Copyright Monash Health. Not for use without prior written permission.

Ms Helen Brunt

BA (Hons), GAICD

Member, Audit Committee
Member, Finance Committee

Term of appointment: July 2019 – current

Ms Brunt is a senior governance and technology delivery executive who brings extensive experience in digital technology and largescale transformation in complex business environments including Wesfarmers and Westpac.

She is skilled in developing strategies to leverage technology to support business strategy. Ms Brunt is passionate about diversity and the use of technology to transform customer and employees experience and previously served as an associate board member for the VIC ICT for Women in IT.

She has previously served as an elected Member Director of the Wesfarmers Super Trust Policy Committee.

Misty-Jenkins-028-2021 Board&Exec

Associate Professor Misty Jenkins

BSc (Hons), PhD, MAICD

Member, Quality Committee
Member, Aboriginal Health Strategic Partnership Committee

Term of appointment: November 2016 – current

Dr Jenkins is a leading biomedical scientist and laboratory head at Walter and Eliza Hall Institute for Medical Research, where she researches cellular immunology and new immunotherapies for cancer. Dr Jenkins has previously held postdoctoral positions at the Universities of Cambridge and Oxford, and The Peter MacCallum Cancer Centre in Melbourne. Dr Jenkins was awarded the L’Oreal for Women in Science Fellowship (2013), was Tall Poppy of the Year (2015) and won the Westpac/Australian Financial Review 100 Women of Influence award (2016). In addition to her research career, Dr Jenkins has a decade of experience in governance as a non-executive Director in both the health and education sector, including Indigenous Health, and holds Chair positions at the NHMRC and Medical Research Future Fund (MRFF).

Peter-McDougall028-2021 Board&Exec

Professor Peter McDougall

MB, BS, FRACP, MBA, GAICD

Member, Quality Committee
Member, Primary Care and Population Health Advisory Committee
Term of appointment: July 2020 – current

Peter McDougall trained in paediatrics as a neonatologist at The Royal Children’s Hospital, Melbourne and the Bristol Maternity Hospital, UK returning to the RCH as a consultant neonatologist in 1984. In 1998 he was appointed Chief of Medicine and Head of Neonatology. He served as Executive Director of Medical Services and Clinical Governance, Chief Medical Officer at RCH from 2010 until 2018. With Associate Professor David Armstrong, he served as the co-clinical lead of the Victorian Paediatric Clinical Network, Safer Care Victoria from 2014-2018 and was a member of the Consultative Council on Obstetric and Paediatric Mortality and Morbidity (CCOPMM), DHHS from 1991-2018. He was appointed Honorary Clinical Professor with the University of Melbourne Department of Paediatrics in 2015.

Peter has had a longstanding commitment to quality and safety in hospital services and currently is a Senior Clinical Advisor to CCOPMM.

Robyn-McLeod-028-2021 Board&Exec

Ms Robyn McLeod

BA, BEd, GAICD

Member, Community Advisory Committee
Member, Finance Committee

Term of appointment: July 2019 – current

Ms McLeod is a governance and public policy expert who currently serves on the Boards of Melbourne Water and VicWater, and previously served as a member of the Governance working group of the Board of Good Shepherd Australia and New Zealand.

Her previous positions include Director of the Australian Centre for Social Innovation, Independent Commissioner for Water Security in South Australia, National Director of Water for KPMG, Executive Director of Major Projects Water with the Department of Sustainability and Environment, Victoria and Chief of Staff to the Victorian Energy Resources and Ports Minister.

Hatem-Salem-028-2021 Board&Exec

Emeritus Professor Hatem Salem AM

MB, ChB (Mosul, Iraq), FRACP, FRCPA, MRCP (UK) MD (Monash), LRCP, MRCS

Chair, Quality Committee
Member, Remuneration Committee
Term of appointment: May 2017 – current

Professor Salem is an Emeritus Professor at Monash University. Prior to this, Professor Salem was the Head of the Academic Department of Clinical Haematology at Monash University and the Head of Clinical Haematology at the Alfred Hospital.

He served as President of Asia Pacific Society of Thrombosis and Haemostasis and past president and Executive Director of the Australasian Society of Thrombosis and Hemostasis. He is a senior Counsellor of the International Society of Thrombosis and Haemostasis. In 2005, his vision and ability to develop leading clinical and research programs were recognised by the Victorian Government’s Public Healthcare Award, where he was the recipient of the Health Minister’s Award for Outstanding Individual Achievement.

In 2010, Professor Hatem Salem was awarded the Member of the Order of Australia (AM) for service to medicine in the field of haematology as a clinician, educator and researcher and also through the establishment of the Australian Centre for Blood Diseases.

Book your COVID-19 vaccination -Find out more
+